What is the rank of Sun Pharma in India?
What is the rank of Sun Pharma in India?
Top 10 Publicly Listed pharmaceutical companies in India by Market Capitalization as of 2021.
| Rank | Company | Market Capitalization 2021 (INR crores) |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 1,96,829 Crore |
| 2 | Divi’s Laboratories Ltd. | 1,38,525 Crore |
| 3 | Dr. Reddy’s Laboratories Ltd. | 83,744 Crore |
| 4 | Cipla Ltd. | 75,398 Crore |
What is the rank of Sun Pharma?
Today it is ranked No.1 by prescriptions with 9 different classes of doctors in India and a market leader in cardiology, gastroenterology, ortho, diabetology, dermatology, urology, and vitamins / minerals / nutrients.
What is the P ratio of Sun Pharma?
33.3x
PE vs Industry: SUNPHARMA is poor value based on its PE Ratio (33.3x) compared to the Indian Pharmaceuticals industry average (25.6x).
What is the salary of CEO of Sun Pharma?
The typical Sun Pharma Senior Executive salary is ₹7,26,772 per year. Senior Executive salaries at Sun Pharma can range from ₹2,17,896 – ₹12,55,100 per year. This estimate is based upon 12 Sun Pharma Senior Executive salary report(s) provided by employees or estimated based upon statistical methods.
What is future of pharma sector?
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to reach ~US$ 120-130 billion by 2030.
Is Sun Pharma undervalued?
Sun Pharma’s potential in the specialty business is undervalued. When it comes to Cipla, the market is watching what will happen because of the second wave and the higher revenues that the company is going to enjoy because of that.
What is a CEO salary in India?
The average salary for a CEO in India is ₹31,188,997 per year. The salary range for a CEO is between ₹15,447,910 and ₹62,961,228. While we are seeing hourly wages as high as ₹30,270 and as low as ₹7,427, the majority of CEOs are currently paid an average of ₹14,995 in India.
What is the salary of CEO of Cipla?
Umang Vohra Managing Director and Global Chief Executive Office of Cipla Limited was paid 20.23 per cent less when compared to FY 18 to Rs 15.03 crore remuneration in 2018-19. Vohra received Rs 18.85 crore in 2017-18. (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)
What is the best medicine company?
Top ten pharma companies in 2020
- Roche – $49.23bn.
- Novartis – $47.45bn.
- Merck & Co. – $46.84bn.
- GlaxoSmithKline – $44.27bn.
- Sanofi – $40.46bn.
- AbbVie – $33.26bn.
- Takeda – $30.52bn.
- Shanghai Pharmaceuticals Holding – $26.69bn.
What is the share price of Sun Pharma?
550% (The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. 1/- each of the Company for the financial year ending on March 31, 2021.) Sun Pharma.Inds. Loading…
What is the dividend yield of Sun Pharmaceutical Industries?
For the year ending March 2019 Sun Pharmaceutical Industries has declared an equity dividend of 275.00% amounting to Rs 2.75 per share. At the current share price of Rs 452.10 this results in a dividend yield of 0.61%.
What are the disclosures of Sun Pharmaceutical Industries?
Sun Pharmaceutical Industries – Disclosures under Reg. 31 (1) and 31 (2) of SEBI (SAST) Regulations, 2011. The Exchange has received Disclosure under Regulation 31 (1) and 31 (2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2….
What is Piotroski F score of Sun Pharma?
Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company. Promoters unpledged 0.39% of shares in last quarter. Total pledge stands at 8.62% of promoter holdings Mutual Funds have increased holdings from 10.99% to 11.93% in Mar 2021 qtr.